ALM201

Home
Ligands
ALM201

GtoPdb Ligand ID: 11485

Compound class: Peptide or derivative

Comment: ALM201 is a small 23 amino acid peptide that is derived from the FK506 binding protein FKBPL. It has anti-angiogenic and anti-tumour activities [2].

Summary
Biological activity
Clinical data
References
Structure

No information available.

No information available.

Summary of Clinical Use
ALM201 has completed Phase 1a clinical evaluation, and was granted FDA orphan drug designation for ovarian cancer in 2017 [1].

Summary of Clinical Use

ALM201 has completed Phase 1a clinical evaluation, and was granted FDA orphan drug designation for ovarian cancer in 2017 [1].

Clinical Trials
Clinical Trial ID	Title	Type	Source	Comment	References
NCT03427073	A Phase I Dose-escalation Study of Subcutaneous ALM201 in Patients With Advanced Ovarian Cancer and Other Solid Tumours	Phase 1 Interventional	Almac Discovery